Phase II Study of Neoadjuvant Imatinib in Glioblastoma: Evaluation of Clinical and Molecular Effects of the Treatment

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-1867
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Multicenter Phase II Clinical Trial of Nilotinib for Patients With Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia From the East Japan CML Study Group Evaluation of Molecular Response and the Efficacy and Safety of Nilotinib

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2014English

A Phase II Study of Cetuximab, Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Locally Advanced Resectable Rectal Cancer

European Journal of Surgical Oncology
MedicineOncologySurgery
2010English

Phase II Pilot Study of Imatinib Mesylate for the Treatment of Severe Sclerotic Skin Chronic Graft Versus Host Disease (ScGVHD)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation in the Treatment of Pleural Mesothelioma

BMC Cancer
Cancer ResearchOncologyGenetics
2013English

P2.17-27 IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC With Atezolizumab + Chemotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Comparative Evaluation of Clinical Response and Toxicities Between Neoadjuvant Chemoradiation Versus Radiation Alone in the Treatment of Advanced Stage (Stage II and III) of Rectal Carcinoma

Journal of Medical Science And clinical Research
2019English

Glioblastoma Update: Molecular Biology, Diagnosis, Treatment, Response Assessment, and Translational Clinical Trials

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Molecular and Clinical Insights Into the Invasive Capacity of Glioblastoma Cells

Journal of Oncology
Oncology
2019English

Imatinib and Everolimus in Patients With Progressing Advanced Chordoma: A Phase 2 Clinical Study

Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy